Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity
Т. А. Гудашева, P. Yu. Povarnina, Алексей Валерьевич Тарасюк, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 6, pp. 729-737
Closed Access | Times Cited: 25

Showing 25 citing articles:

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
Amjad H. Bazzari, Firas H. Bazzari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8417-8417
Open Access | Times Cited: 40
Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties
Т. А. Гудашева, P. Yu. Povarnina, Алексей Валерьевич Тарасюк, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 5, pp. 2746-2774
Closed Access | Times Cited: 49
Optimized integration of fluoxetine and 7, 8-dihydroxyflavone as an efficient therapy for reversing depressive-like behavior in mice during the perimenopausal period
Nashwa Amin, Shiyi Xie, Xiaoning Tan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 101, pp. 109939-109939
Closed Access | Times Cited: 40
Snake venom nerve growth factor-inspired designing of novel peptide therapeutics for the prevention of paraquat-induced apoptosis, neurodegeneration, and alteration of metabolic pathway genes in the rat pheochromocytoma PC-12 cell
Dev Madhubala, Aparup Patra, Taufikul Islam, et al.
Free Radical Biology and Medicine (2023) Vol. 197, pp. 23-45
Closed Access | Times Cited: 13
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development
Guoqi Zhu, Shaojie Yang
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1479-1497
Open Access | Times Cited: 31
Ginsenoside Rh2 administration produces crucial antidepressant‐like effects in a CUMS‐induced mice model of depression
Lin‐Sheng Shi, Chun‐Hui Ji, Yue Liu, et al.
Brain and Behavior (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 20
Snake Venom-Inspired Novel Peptides Protect Caenorhabditis elegans against Paraquat-Induced Parkinson’s Pathology
Dev Madhubala, Rosy Mahato, Kangkon Saikia, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Сhronically Administered BDNF Dipeptide Mimetic GSB-106 Prevents the Depressive-like Behavior and Memory Impairments after Transient Middle Cerebral Artery Occlusion in Rats
Т. А. Гудашева, P. Yu. Povarnina, Т. А. Антипова, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 2, pp. 126-132
Open Access | Times Cited: 9
Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling
Yulia V. Vakhitova, Т. С. Калинина, Л. Ф. Зайнуллина, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13381-13381
Open Access | Times Cited: 18
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression and Anti-depression Action of Venlafaxine in the Hippocampus of Mice
Wei Guan, Xinyuan Wu, Xiang Jin, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 22, pp. 3412-3425
Closed Access | Times Cited: 7
ERRγ Ligand Regulates Adult Neurogenesis and Depression-like Behavior in a LRRK2-G2019S-associated Young Female Mouse Model of Parkinson's Disease
Hyo In Kim, Juhee Lim, Hyo‐Jung Choi, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1298-1312
Open Access | Times Cited: 12
Mitogen and Stress-activated Protein Kinase 1 Negatively Regulates Hippocampal Neurogenesis
Oladiran I. Olateju, Lorenzo Morè, J. Simon C. Arthur, et al.
Neuroscience (2020) Vol. 452, pp. 228-234
Open Access | Times Cited: 14
Snake venom-inspired novel peptides protectCaenorhabditis elegansagainst paraquat-induced Parkinson’s pathology
Dev Madhubala, Kangkon Saikia, Aparup Patra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Antidepressant-like effects of 1-methylnicotinamide in a chronic unpredictable mild stress model of depression
Jie Zhao, Yin Zhang⋆, Yue Liu, et al.
Neuroscience Letters (2020) Vol. 742, pp. 135535-135535
Closed Access | Times Cited: 10
Neurotrophin Regulation and Signaling in Airway Smooth Muscle
B. Roos, Jacob J. Teske, Sangeeta Bhallamudi, et al.
Advances in experimental medicine and biology (2021), pp. 109-121
Closed Access | Times Cited: 4
Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke
Т. А. Гудашева, P. Yu. Povarnina, Т. А. Антипова, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 20, Iss. 10, pp. 954-962
Closed Access | Times Cited: 4
Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases
Dev Madhubala, Rosy Mahato, Mojibur R. Khan, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104156-104156
Closed Access
Induction of Apoptosis by 7,8-Dihydroxyflavone, a Plant Flavonoid, in Human Hepatocellular Carcinoma HepG2 Cells
Hyun Hwangbo, Yung Hyun Choi
Journal of the Korean Society of Food Science and Nutrition (2024) Vol. 53, Iss. 10, pp. 1021-1029
Open Access
Impact and Mechanisms of Action of BDNF on Neurological Disorders, Cancer, and Cardiovascular Diseases
Min Lei, Qiwen Liu, Jing Nie, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access
Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology
Алексей Валерьевич Тарасюк, Yuri V. Mezentsev, O.V. Gnedenko, et al.
Pharmacokinetics and Pharmacodynamics (2023), Iss. 4, pp. 50-54
Open Access | Times Cited: 1
Counteracting health risks by Modulating Homeostatic Signaling
Junqiang Tian, Mark A. Levy, Zhang Xuekai, et al.
Pharmacological Research (2022) Vol. 182, pp. 106281-106281
Open Access | Times Cited: 2
Design and Synthesis of Dipeptide Nerve Growth Factor Loop 1 Mimetics and In Vitro Studies of their Neuroprotective and Differentiation-Inducing Activities
A. V. Tarasyuk, Н. М. Сазонова, A. G. Rebeko, et al.
Pharmaceutical Chemistry Journal (2021) Vol. 54, Iss. 11, pp. 1126-1135
Closed Access | Times Cited: 1
Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part I
Vasily N. Sukhorukov, Alexander N. Orekhov
Current Pharmaceutical Design (2019) Vol. 25, Iss. 3, pp. 211-212
Closed Access
Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part II
Vasily N. Sukhorukov, Alexander N. Orekhov
Current Pharmaceutical Design (2019) Vol. 25, Iss. 6, pp. 625-626
Closed Access
The mimetic of the brain neurotrophic factor GSB-106 has neuroprotective and neuroregenerative effects in experimental ischemic stroke
P. Yu. Povarnina, Т. А. Антипова, И. О. Логвинов, et al.
Pharmacokinetics and Pharmacodynamics (2022), Iss. 1, pp. 36-43
Open Access
Page 1

Scroll to top